retinitis pigmentosa
Conditions
Interventions
control subjects:Topical external treatment of the eye
acupuncture point
Intravenous administration of Puerarin for injection
Placebo granules.
test group:Topical external treatment of the eye
Sponsors
Eye hospital China academy of Chinese medicine sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: A. diagnosis of primary retinitis pigmentosa B. Age: 18-75 years old C. best corrected visual acuity ETDRS = 15 letters D. OCTOPUS visual field >10 degrees E.Chinese medicine evidence: patients with evidence of deficiency of liver and kidney can be enrolled if they meet 1 main symptom + 1 secondary symptom F. Patients who are using other vasodilators or neurotrophic drugs can be enrolled only after 4 weeks of drug cessation. G. Sign the informed consent form
Exclusion criteria
Exclusion criteria: A. Suffering from other fundus diseases B. Suffer from glaucoma corneal disease and other diseases that affect vision C. No light perception in the affected eye D. Suffering from serious systemic diseases heart liver and kidney insufficiency E. Suffering from other hereditary diseases F. Are using other methods or participating in other studies G. Patients who are pregnant or breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual field examination (30° and 90° visual fields); | — |
Secondary
| Measure | Time frame |
|---|---|
| Best-corrected visual acuity (ETDRS visual acuity);hemodynamic testing;Use OCTA to check macular retinal thickness and retinal blood flow density;Chinese medicine evidence score; | — |
Countries
China
Contacts
Public Contactsongjiantao
Eye hospital China academy of Chinese medicine sciences
Outcome results
None listed